Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000464964 | SCV000559938 | benign | Adams-Oliver syndrome 5 | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001704575 | SCV000714613 | likely benign | not provided | 2019-04-22 | criteria provided, single submitter | clinical testing | In silico analysis, which includes splice predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; Nucleotide substitution has no predicted effect on splicing and is not conserved across species; Has not been previously published as pathogenic or benign to our knowledge |
Ambry Genetics | RCV002313221 | SCV000739435 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2016-07-08 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV000464964 | SCV002555171 | benign | Adams-Oliver syndrome 5 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002270542 | SCV002555172 | benign | Aortic valve disease 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001704575 | SCV004162068 | likely benign | not provided | 2022-12-01 | criteria provided, single submitter | clinical testing | NOTCH1: BP4, BP7, BS1 |
Breakthrough Genomics, |
RCV001704575 | SCV005228715 | likely benign | not provided | criteria provided, single submitter | not provided |